Clean Science and Technology Limited (NSE: CLEAN, BSE: 543318) – Outcome of 23rd Annual General Meeting (12 Sept 2026)

Introduction

On 12 September 2026, Clean Science and Technology Limited (the “Company”) convened its 23rd Annual General Meeting (AGM) via Video Conferencing/Other Audio‑Visual Means (VC/OAVM). The meeting was held in accordance with the Companies Act, 2013 and SEBI (LODR) Regulations, 2015. A total of 63 shareholders participated through the VC platform, and the voting was conducted through a combined remote e‑voting and on‑site e‑voting process.

---

Key Outcomes of the AGM

No.	Resolution (Ordinary/Special)	Core Decision	Voting Outcome*
1	Adoption of Audited Standalone Financial Statements FY 2025‑26	Approved	99.9999 % in favour (83,813,635 votes)
2	Adoption of Audited Consolidated Financial Statements FY 2025‑26	Approved	99.9999 % in favour (83,813,550 votes)
3	Dividend – Interim ₹2 per share (200 %) & Final ₹4 per share (400 %)	Approved	99.9999 % in favour (83,899,636 votes)
4	Re‑appointment of Mr. Krishnakumar Ramnarayan Boob (Whole‑Time Director)	Approved	99.662 % in favour (83,615,746 votes)
5	Ratification of Cost Auditor remuneration for FY 2026‑27	Approved	99.9999 % in favour (83,899,639 votes)
6	Appointment of Mr. Krishnakumar Satyanarain Saboo as Whole‑Time Director (5‑year term)	Approved	97.393 % in favour (24,855,298 votes)
7	Approval of Commission to Non‑Executive Directors for FY 2026‑27	Approved	99.9815 % in favour (38,654,016 votes)

*Percentages are calculated on the total votes cast for each resolution. “In favour” votes exceeded the required majority for all items; “Against” votes were negligible (≤ 0.34 %). No invalid votes were recorded for most resolutions.

Dividend Declaration

• Interim dividend: ₹2 per equity share (200 % of face value).
• Final dividend: ₹4 per equity share (400 % of face value).
  Both dividends are payable on the fully paid‑up equity share of ₹1 each.

Board Changes

• Re‑appointment: Mr. Krishnakumar Ramnarayan Boob continues as Whole‑Time Director.
• New appointment: Mr. Krishnakumar Satyanarain Saboo appointed as Whole‑Time Director for a five‑year term (1 Aug 2026 – 31 Jul 2031).

Other Resolutions

• Adoption of audited standalone and consolidated financial statements for FY 2025‑26.
• Ratification of remuneration to the Cost Auditors for FY 2026‑27.
• Approval of commission payable to non‑executive directors for FY 2026‑27.

---

Procedural Highlights

• Quorum & Attendance: 63 shareholders attended via video conference; no physical proxy votes were cast.
• Voting Mechanism: Remote e‑voting ran from 8 Sept 2026 09:00 IST to 11 Sept 2026 17:00 IST, followed by on‑site e‑voting during the AGM.
• Scrutinizer Report: J.B. Bhave & Co. acted as the Scrutinizer, confirming the integrity of the e‑voting process and the validity of the results.
• Regulatory Compliance: The AGM complied with SEBI (LODR) Regulations, 2015, and the relevant MCA circulars; all documents (including the statutory registers, director contracts, ESOP certificates, etc.) were made available on the Company’s website and the NSDL e‑voting portal.

---

Investor Take‑aways

• Strong Shareholder Support: All seven resolutions received overwhelming approval, indicating robust shareholder confidence in the Company’s financial reporting, dividend policy, and governance decisions.
• Dividend Payout: The declared interim and final dividends represent a total payout of ₹6 per share for FY 2025‑26, reflecting the Company’s commitment to returning cash to shareholders.
• Board Stability & Succession: The re‑appointment of an existing Whole‑Time Director and the addition of a new Whole‑Time Director ensure continuity in management while bringing fresh leadership for the next five years.
• Compliance Assurance: The e‑voting process was independently scrutinized and found to be transparent and compliant, mitigating any procedural risk.

The Company has uploaded the detailed voting tables, Scrutinizer’s report, and related documents on its website (www.cleanscience.co.in) and on the NSDL e‑voting portal.